David Guy Kirsch is an American oncologist currently the Barbara Levine University Professor at Duke University[1] and an Elected Fellow of the American Association for the Advancement of Science.
[2] He earned his M.D.
and Ph.D. at Johns Hopkins University School of Medicine in 2000.
[3] His interests are in studying sarcomagenesis, cancer biology and radiation oncology.
[2] His highest cited papers are "Conversion of Bcl-2 to a Bax-like death effector by caspases",[4] at 1332 times, and "Restoration of p53 function leads to tumour regression in vivo",[5] at 1320 times, according to Google Scholar.